ABSTRACT Background
INTRODUCTION
Hypertension (HTN) is a global public health problem contributing substantially to the burden of noncommunicable diseases. 1, 2 It is one of the major risk factors for cardiovascular diseases (CVDs), 1 from which an estimated 17.3 million people worldwide die each year, a number expected to rise to 23.3 million by 2030.
1 Over 80% of these deaths occur in low-and middle-income countries, and the suggestion has been made that HTN is significantly more prevalent in low-income countries. 1 However, good population-based studies are resource-demanding and not easily performed in these countries, which tend to have poor infrastructure and regions of difficult access.
Nepal is a low-income country, with approximately 30 million people. Geographically, ethnically and culturally diverse, 3 its landscape spans three physiographic divisions: Mountain (which includes the Himalayan peaks), Hill (essentially the Himalayan foothills) and Terai (plains up to 200 m above sea level). From East to West, the country is divided into five developmental regions. There were very limited data on HTN or CVDs in Nepal until decades ago. 4 Current estimates of the prevalence of HTN, in the range 18.8 -41.8%, are based on diverse populations from different localities and various points of time.
1 A study in Dharan, a town of Eastern Nepal, found the prevalence of HTN to be close to 23%
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; a community-based study in rural Kathmandu found it to be 33.8% 6 ; a broader study of HTN, obesity, diabetes and metabolic syndrome in Eastern Nepal found a very similar 33.9%. 7 While these studies indicated a high prevalence of HTN in the Nepalese population, none were nationwide and there has been no publication exploring HTN on a national level.
We were able to take advantage of a carefully-conducted nationwide survey of major disorders of the brain in adult general population of Nepal, carried out during May 2013.
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One of the variables of interest was blood pressure (BP). We therefore sought to establish the prevalence of elevated BP (eBP), and factors associated with it. In the context of this survey we could not collect data on any antihypertensive therapy being taken, but took the view that, whatever this might have been, it was failing to meet treatment needs. Therefore, the prevalence of eBP (treated or not) was indicative of unmet health-care need.
METHODS
The study was part of a nationwide epidemiological survey addressing major disorders of the brain in Nepal, of which the methods have been published in detail. 8, 9 It was approved by the Nepal Health Research Council (NHRC), the Institutional Review Committee of Kathmandu University School of Medical Sciences, Dhulikhel Hospital (IRC-KUSMS), and the Central Regional Committee for Health and Research Ethics in Norway.
Study Design
The survey was a cross-sectional study, conducted by unannounced household visits, employing multistage random cluster sampling. To achieve representativeness, 15 districts out of 75 in the country were sampled: one district from each of the three physiographic divisions (Mountain, Hill and Terai) in each of the five development regions of Nepal (Fig. 1) . We ensured that numbers sampled from each of the physiographic divisions were proportional to populations within those divisions. One adult aged 18-65 years was selected from each included household and interviewed by structured questionnaire. We excluded immigrants and those with major physical or mental health disorders.
All data were collected within the month of May, 2013.
Blood pressure measurement
We used a digital device (Microlife 3BM1-3®). The participant sat on the floor to ensure uniformity since most Nepalese homes did not have a chair available. We took two readings from the right arm, with a rest in between. If either reading was above 140/90 mm Hg, the measurement was repeated after a further two minutes of rest. We used the averages of the systolic and diastolic measurements. Then we categorized the BP according to the criteria of the Joint National Committee 7 th report (JNC7).
10 All measurements with SBP≥140 or DBP≥90 or SBP>140 and DBP>90 mmHg were considered eBP; rest were all considered normotensives.
Data analysis
Analyses were carried out using the Statistical Package for Social Science (IBM SPSS Statistics 21). Prevalence of eBP was calculated as percentages with 95% confidence intervals (CIs). We used bivariate and multivariate logistic regression to evaluate associations between eBP and candidate factors, calculating odds ratios (ORs) and adjusted ORs (AORs) respectively. The following variables were included in the analytical models: gender, age, urban vs rural habitation, household altitude (≥2000 vs <2000 m), The results of bivariate and multivariate logistic regression analyses are set out in Table 2 , and confirm the strong male propensity for eBP (OR 2.4; AOR 1.8). The prevalence of eBP increased with age, peaking in the oldest age group 60-65 years (OR 15,9; AOR 14.0. Bivariate analysis showed that the prevalence of eBP was positively associated with smoking and alcohol consumption at least once a week and highly associated with daily alcohol consumption. It was also associated with BMI ≥25. Multivariate analysis confirmed that all these factors except smoking were independently associated with eBP (Table 2) .
DISCUSSION
This first nationwide population-based study in Nepal to estimate the adult prevalence of eBP had multiple strengths. We recruited a large sample (2,100) from the whole country, inclusive of its ethnic, cultural and geographical diversities, engaged participants in face-to-face interviews for better data quality and strongly promoted representativeness through a participation rate of >99%. We measured BP in participants' own homes, using a standardised procedure and similar devices. We collected all data within a month. The principal limitation was the cross-sectional design of the study, so that we could not establish causation in any associations between eBP and other variables.
The overall prevalence of eBP was 15.1% -almost one in six adults aged 18-65 years. Prevalence of eBP was positively associated with age, male gender, alcohol consumption, BMI ≥25 and altitude ≥ 2000 m. Many studies, including two in Nepal, 5, 17 have reported that the prevalence of HTN increases with age and there is a very large literature on the biology of this association. 17, 18 We observed the agerelated increase in eBP prevalence, occurring in both genders, was more than ten-fold between 18-19 and 60-65 years.
Studies elsewhere have also shown HTN to be more prevalent among men than women, [11] [12] [13] although there are some with the opposite finding or showing no gender difference.
14-16 A preponderance of HTN in men may be explained by differential risk factors between women and men across populations. The positive association that we observed of eBP with male gender is in line with earlier regional studies in Nepal. 6, 17 Culturally, men in Nepal may be more exposed than women to life-style factors such as alcohol consumption and tobacco smoking. These are modifiable factors but, although the former at least showed a strong and progressive association with eBP, in this cross-sectional study we could not demonstrate any causal link to identify them as risk factors. Alcohol consumption is an important life-style habits that is positively associated with HTN. 17, 20 We found that daily alcohol consumers were three times more likely to have eBP than teetotallers. Cigarette smoking may increase BP by increasing sympathetic activity. 19 It is important to point out that our data, similar to other studies, have shown that smokers have not significantly higher BP than nonsmokers. This lack of association may be explained by the fact that we analysed data only from current smokers and not those who might have changed their smoking habits after identification of HTN.
Being overweight or obese is also an important risk factor for HTN, 21 because of the adverse metabolic effects on BP.
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In line with other studies in Nepal, 5, 17 we found BMI ≥25 kg/m 2 to be positively associated with eBP.
Finally, we found a higher prevalence of eBP in people residing at altitudes of ≥2000 m. Studies of the relationship between high altitude and hypertension in a populationbased study are rather rare. Hypoxia is one possible explanation for this association: chronic hypoxia causes marked activation of the sympathetic nervous system in healthy humans and also increased arterial pressure.
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Implications for health and health care
Whereas the overall prevalence of eBP was 15.1%, two thirds of these cases (10.9%) would be classified according to JNC7 criteria as Stage I hypertensive and the remainder (4.2%) as Stage II hypertensive. Crucially, these findings were despite any antihypertensive therapy that was being made available, and are therefore a measure of the extent to which such therapy was not achieving its public-health objective (ie, of unmet health-care need). The importance of this in public-health terms lies in the substantial health risks ensuing from HTN, including and especially those leading to CVDs.
The significantly higher number of eBP cases in the Himalayas and Hills probably indicate the necessity of treatment or educational campaign regarding the importance of contact with the physician in the high altitude regions. Similarly, the role of modifiable risk factors (more importantly substances of abuse and other dietary factors) in the occurrence of HTN also needs particular emphasis with the public health point of view.
CONCLUSION
Almost one in six adults in this survey had eBP, meeting JNC7 criteria for hypertension. The survey could not collect data on any antihypertensive therapy being taken but, whatever this might have been, it was failing to meet treatment needs. This level of untreated or inadequately treated eBP carries major risk implications for CVDs, and represents a substantial threat to public health. The study therefore discloses and gives a measure of unmet healthcare need in Nepal. Two remediable associated factors were identified, although in a cross-sectional survey we could not prove causation.
